Light-activated cancer drugs without toxic side effects: Fresh insight

Future cancer drugs that are activated by light and don't cause the toxic side-effects of current chemotherapy treatments are closer to becoming a reality, thanks to new research by the University of Warwick and Monash University Cancer drugs activated by light, minimizing toxic side-effects, are a step closer thanks to new research from University of … Continue reading Light-activated cancer drugs without toxic side effects: Fresh insight

Advertisements

Nanosensor that lights up cancer to be tested in surgeries

UT Southwestern Simmons Cancer Center scientists next month will begin testing a digital nanosensor that lights up cancer tissue to see whether it can improve the accuracy of cancer surgeries, thereby reducing cancer recurrence and surgical morbidity. The nanosensor, which works by reacting to low pH, illuminates cancer like a lightbulb, sharply distinguishing cancerous tissue … Continue reading Nanosensor that lights up cancer to be tested in surgeries

Leukaemia treatment can be made more effective by using a drug for iron overload

Chemotherapy for one type of leukaemia could be improved by giving patients a drug currently used to treat an unrelated condition, new research shows. Acute myeloid leukaemia (AML) is an aggressive cancer that stops healthy blood cell production. Chemotherapy is the standard treatment, but improvements are needed as the five-year survival rate in patients older … Continue reading Leukaemia treatment can be made more effective by using a drug for iron overload

After the diagnosis: How cancer affects sexual functioning

A cancer diagnosis disrupts a person's life in many ways, including sexually. A study led by the University of Houston found that more than half of young cancer patients reported problems with sexual function, with the probability of reporting sexual dysfunction increasing over time. The study, recently published in the American Cancer Society journal Cancer, discovered … Continue reading After the diagnosis: How cancer affects sexual functioning

Many brain tumor patients do not receive adequate end-of-life care

While more than 60 percent of patients with the brain tumors called malignant gliomas enroll in hospice services, almost a quarter of them do so within a week of death, probably too late for patients and family members to benefit from hospice care. A study by a research team from the Massachusetts General Hospital (MGH) Cancer Center also … Continue reading Many brain tumor patients do not receive adequate end-of-life care

Scientists link pancreatic cancer survival to four genes

Alterations in four main genes are responsible for how long patients survive with pancreatic cancer, according to a new study in JAMA Oncology. Before now, the presence and patterns between the genes and disease progression was not clearly established. One key difference in this study is the relatively large size: it involved 356 patients who all had … Continue reading Scientists link pancreatic cancer survival to four genes

Combined therapies increase side effects for patients with advanced breast cancer

Patients with advanced breast cancer who are treated with a combination of drugs that target specific molecules important for cancer development and also the hormones that are driving it are at increased risk of suffering adverse side effects. In new research presented at the Advanced Breast Cancer Fourth International Consensus Conference (ABC 4), researchers have … Continue reading Combined therapies increase side effects for patients with advanced breast cancer

Cholesterol byproduct hijacks immune cells to spread breast cancer

High cholesterol levels have been associated with breast cancer spreading to other sites in the body, but doctors and researchers don't know the cause for the link. A new study by University of Illinois researchers found that the culprit is a byproduct of cholesterol metabolism that acts on specific immune cells so that they facilitate … Continue reading Cholesterol byproduct hijacks immune cells to spread breast cancer

Study reveals complex biology of gender differences in kidney cancer

A new study is believed to be the first to describe the unique role of androgens in kidney cancer, and it suggests that a new approach to treatment, targeting the androgen receptor (AR), is worth further investigation. The research was led by senior author Chawnshang Chang, Ph.D., the George Hoyt Whipple Distinguished Professor of Pathology, … Continue reading Study reveals complex biology of gender differences in kidney cancer

Breast cancer patients on opioids less likely to stick to vital treatment

A new study has found a troubling lack of adherence to a potentially lifesaving treatment regimen among breast cancer patients who take opioids to manage their pain. The treatment, adjuvant endocrine therapy, commonly known as hormone therapy, is used to prevent the cancer from returning after surgery, chemotherapy or radiation therapy. Opioid use, however, was … Continue reading Breast cancer patients on opioids less likely to stick to vital treatment